X

FINANCIAL STATEMENTS

Sava Re GROUP

Consolidated statement of cash flows

(€)

Notes

1-12/2017

1-12/2016

A. Cash flows from operating activities

 

a)

Items of the income statement

36

29,652,140

49,825,078

   

1.

Net premiums written in the period

28

482,990,135

458,962,640

   

2.

Investment income (other than financial income)

29

143,722

210,989

   

3.

Other operating income (excl, revaluation income and releases from provisions) and financial income from operating receivables

 

21,487,720

24,727,042

   

4.

Net claims payments in the period

31

-293,880,632

-254,626,142

   

5.

Expenses for bonuses and rebates

 

5,848

-1,263,545

   

6.

Net operating expenses excl, depreciation/amortisation and change in deferred acquisition costs

33

-151,825,973

-150,471,848

   

7.

Investment expenses (excluding amortisation and financial expenses)

 

-54,102

-133,069

   

8.

Other operating expenses excl. depreciation/amortisation (other than for revaluation and excl. additions to provisions)

34

-20,428,503

-19,829,215

   

9.

Tax on profit and other taxes not included in operating expenses

35

-8,786,075

-7,751,774

 

b)

Changes in net operating assets (receivables for premium, other receivables, other assets and deferred tax assets/liabilities) of operating items of the income statement

 

1,698,017

-7,642,805

   

1.

Change in receivables from primary insurance

9

-72,983,726

169,946

   

2.

Change in receivables from reinsurance

9

61,807,865

752,004

   

3.

Change in other receivables from (re)insurance business

9

365,290

669,194

   

4.

Change in other receivables and other assets

9

-2,880,757

-4,301,734

   

5.

Change in deferred tax assets

3

218,499

45,794

   

6.

Change in inventories

 

-28,879

4,428

   

7.

Change in liabilities arising out of primary insurance

25

42,801,036

941,388

   

8.

Change in liabilities arising out of reinsurance business

25

-31,132,515

-3,446,714

   

9.

Change in other operating liabilities

26

-2,442,917

-4,410,572

   

10.

Change in other liabilities (except unearned premiums)

26

6,231,258

493,561

   

11.

Change in deferred tax liabilities

3

-257,137

1,439,900

 

c)

Net cash from/used in operating activities (a + b)

 

31,350,157

42,182,273

B. Cash flows from investing activities

 

a)

Cash receipts from investing activities

 

1,416,437,638

1,577,964,374

   

1.

Interest received from investing activities

 

18,607,327

21,233,656

   

2.

Cash receipts from dividends and participation in the profit of others

 

1,141,433

1,284,400

   

3.

Proceeds from sale of intangible assets

 

0

5,664

   

4.

Proceeds from sale of property and equipment

 

2,707,118

4,162,273

   

5.

Proceeds from sale of financial investments

 

1,393,981,760

1,551,278,381

 

b)

Cash disbursements in investing activities

 

-1,405,529,717

-1,563,064,826

   

1.

Purchase of intangible assets

 

-1,177,107

-1,022,400

   

2.

Purchase of property and equipment

 

-4,833,554

-6,895,120

   

3.

Purchase of long-term financial investments

 

-1,399,519,056

-1,555,147,306

 

c)

Net cash from/used in investing activities (a + b)

 

10,907,921

14,899,548

C. Cash flows from financing activities

 

b)

Cash disbursements in financing activities

 

-38,241,119

-27,853,565

   

1.

Interest paid

 

-718,860

-842,126

   

3.

Repayment of long-term financial liabilities

 

-24,000.000

0

   

4.

Repayment of short-term financial liabilities

 

-1,058,233

6,080

   

5.

Dividends and other profit participations paid

 

-12,464,026

-12,398,157

   

6.

Own share repurchases

 

0

-14,619,362

 

c)

Net cash from/used in financing activities (a + b)

 

-38,241,119

-27,853,565

C2. Closing balance of cash and cash equivalents

37,956,119

33,939,160

 

x)

Net increase/decrease in cash and cash equivalents for the period (Ac + Bc + Cc)

 

4,016,959

29,228,256

 

y)

Opening balance of cash and cash equivalents

 

33,939,160

4,710,904

The notes to the financial statements in sections 17.4–17.12 form an integral part of these financial statements.
Back to other content